Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/117341
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technologyen_US
dc.creatorLee, TKWen_US
dc.creatorMa, Sen_US
dc.date.accessioned2026-02-12T08:47:59Z-
dc.date.available2026-02-12T08:47:59Z-
dc.identifier.issn0008-5472en_US
dc.identifier.urihttp://hdl.handle.net/10397/117341-
dc.language.isoenen_US
dc.publisherAmerican Association for Cancer Researchen_US
dc.titlePROX1 : a key regulator of hepatocyte identity and tumorigenesisen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage1957en_US
dc.identifier.epage1959en_US
dc.identifier.volume85en_US
dc.identifier.issue11en_US
dc.identifier.doi10.1158/0008-5472.CAN-25-1377en_US
dcterms.abstractDuring ontogeny, the modulation of cell fate plasticity in stem cells is meticulously controlled as they undergo differentiation into distinct cell lineages. Dysregulation of this plasticity can result in pathologic conditions, such as oncogenesis. Transcription factors are pivotal in orchestrating this cellular transition by initiating gene expression programs that define cell identity. Notably, the investigation of transcriptional repressors has garnered significant attention in elucidating the susceptibility to cancer development. A recent research article published in Nature Genetics unveiled the identification of a liver-specific protein named prospero homeobox protein 1 (PROX1), which maintains cellular identity and impedes the initiation and advancement of liver cancer. Analysis of specimens from patients with liver cancer demonstrated a positive association between elevated levels of PROX1 and improved prognosis, as well as extended survival. Utilizing various liver cancer mouse models, the researchers demonstrated that PROX1 can impede tumor initiation and decelerate cancer progression. This study offers valuable insights for potential therapeutic interventions and introduces novel opportunities for investigating “safeguard repressors” in diverse tissue types.en_US
dcterms.accessRightsembargoed accessen_US
dcterms.bibliographicCitationCancer research, 1 June 2025, v. 85, no. 11, p. 1957-1959en_US
dcterms.isPartOfCancer researchen_US
dcterms.issued2025-06-01-
dc.identifier.scopus2-s2.0-105007082094-
dc.identifier.pmid40163354-
dc.identifier.eissn1538-7445en_US
dc.description.validate202602 bcchen_US
dc.description.oaNot applicableen_US
dc.identifier.SubFormIDG000992/2025-11-
dc.description.fundingSourceSelf-fundeden_US
dc.description.pubStatusPublisheden_US
dc.date.embargo2026-06-01en_US
dc.description.oaCategoryGreen (AAM)en_US
Appears in Collections:Journal/Magazine Article
Open Access Information
Status embargoed access
Embargo End Date 2026-06-01
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

SCOPUSTM   
Citations

1
Citations as of May 8, 2026

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.